An anti-monopoly review (反垄断审查, fǎn lǒngduàn shěnchá) is the regulatory assessment conducted by the State Administration for Market Regulation (SAMR) before approving JV formations or acquisitions that could reduce market competition. China’s new anti-monopoly thresholds effective July 1, 2026, lower the filing requirement triggers: JV transactions involving parties with combined global turnover above RMB 1.2 billion (USD 166 million) — down from RMB 4 billion previously — now require mandatory SAMR review, expanding the scope by approximately 35%.
SAMR expects the new thresholds to add roughly 150 to 200 JV filings per year. China has already streamlined some JV approval processes — read our JV Registration Streamlining Report. The highest impact is concentrated per year across the 31 restricted negative-list sectors, with the highest impact concentrated in semiconductors (projected 40 additional filings), EV batteries (35), and healthcare/medical devices (30). Filing fees increase from RMB 250,000 to RMB 400,000 (USD 55,200) under the new regime.
Why This Matters
Failing to file for anti-monopoly review when required can trigger penalties of up to 10%. For the full JV registration timeline including SAMR review, see our JV Registration Timeline FAQ. Penalties can reach of the JV’s annual China revenue or RMB 50 million (USD 6.9 million), whichever is higher. In 2025, SAMR imposed penalties on 7 JVs that bypassed the filing requirement, with the largest fine reaching RMB 82 million (USD 11.3 million).
The lowered threshold catches many international mid-market JVs that previously fell below the RMB 4 billion combined-turnover floor. A joint venture between a German mid-cap auto parts manufacturer (RMB 800 million revenue) and a Chinese battery producer (RMB 500 million revenue) now exceeds the RMB 1.2 billion combined threshold, requiring review where none was needed before.
The Details
- Combined Global Turnover Threshold. JV transactions involving parties with combined global turnover above RMB 1.2 billion (USD 166 million) now require mandatory SAMR review — down from RMB 4 billion, expanding scope by approximately 35%.
- Phase 1 Review Extended to 30 Working Days. Up from 15 working days, while the Fast Track lane processes applications within 12 working days for JVs in encouraged industries.
- Market Competition Impact Analysis (MCIA) Required. A licensed Chinese competition law firm must assess the JV’s impact on market concentration, barriers to entry, and innovation effects.
- 3-Year Post-Approval Monitoring. SAMR can revisit approvals within 3 years if market conditions change substantially, with semiconductor and pharma JVs facing highest re-assessment risk.
The new thresholds apply to both greenfield JV formations and JV-related M&A transactions. For a detailed review of recent approval changes, see MOFCOM JV Approval Changes Review. For greenfield JVs, SAMR assesses and JV-related M&A transactions. For greenfield JVs, SAMR assesses the combined market share of the parents and the structural impact on the relevant product market. Any JV operating in sectors where the parents collectively hold 25% or more market share triggers a mandatory Phase 1 review regardless of the revenue threshold.
Phase 1 review takes 30 working days (up from 15 working days under the previous regime), while Phase 2 (in-depth) review extends to 90 working days. SAMR introduced a Fast Track lane for JVs in encouraged industries — applications are processed within 12 working days with a simplified submission package. In early 2026, 22% of JV filings qualified for Fast Track processing, all in clean energy and medical device sectors.
SAMR now requires a Market Competition Impact Analysis (MCIA) as part of the filing package. This document, prepared by a licensed Chinese competition law firm, must assess the JV’s impact on market concentration (HHI index), barriers to entry, innovation effects, and potential for coordinated effects with existing market players.
The 2026 rules also introduce a 3-year post-approval monitoring period. SAMR can revisit approvals within 3 years if market conditions change substantially — a provision that affects 12 JVs approved in 2025 that have since been notified for re-assessment. JVs in semiconductor and pharmaceutical sectors face the highest re-assessment risk due to rapid market evolution.
Cross-sector SAMR review data. SAMR’s 2025 annual competition report showed that JV filings in the semiconductor sector had the highest Phase 2 referral rate at 38%, followed by EV batteries (31%) and pharmaceuticals (27%). Manufacturing JVs, by contrast, had only 8% Phase 2 referral. The phase 2 review duration averaged 67 working days for referred cases, with semiconductor cases taking an average of 82 working days — nearly 3 times the Phase 1 timeline.
JVs with combined market share below 15% in their sector had a 92% Phase 1 clearance rate, while those above 30% market share faced 65% Phase 2 referral.
International comparison. China’s new RMB 1.2 billion combined turnover threshold, per SAMR, turnover threshold is now more restrictive than the EU’s EUR 500 million (approximately RMB 3.9 billion) and the US’s USD 436 million (approximately RMB 3.15 billion) thresholds. This means JVs that would not trigger review in the EU or US must now file in China — reversing the previous regulatory posture where China’s RMB 4 billion threshold was more lenient. Multinational enterprises operating JVs in multiple jurisdictions now face China as the most stringent anti-monopoly jurisdiction for mid-market JVs, requiring dedicated China competition counsel for deals above RMB 1.2 billion combined turnover.
What You Should Do
Before signing any JV agreement, calculate whether your combined global turnover exceeds RMB 1.2 billion. If it does, budget RMB 400,000 (USD 55,200) in filing fees and allocate at least 45 working days for SAMR review in your JV formation timeline. Engage a SAMR-qualified competition lawyer (反垄断律师, fǎn lǒngduàn lǜshī) before filing — the MCIA document alone requires 4 to 6 weeks of preparation.
Consider whether your JV sector qualifies for Fast Track processing. Sectors on the encouraged industries list — especially clean energy, medical devices, and advanced materials — receive priority. JVs where both foreign and Chinese parents are not competitors in the same market also qualify more readily for simplified review.
Structure your JV agreement to include anti-monopoly approval as a condition precedent (前提条件, qiántí tiáojiàn). The agreement should specify which party bears the filing fee, what happens if review is denied (asset separation mechanism), and a timeline allocation of 60 working days for the full review process.
Where to Go From Here
Based on what you just read:
- Ready to act? Read JV Documents Required FAQ
- Still comparing? See Majority-Owned vs 50/50 JV Comparison
- Need numbers? Try JV Profit Share Calculator
— China Gateway 360 —
Remote China market entry support, built around execution.
